In recent years, private equity firms have acquired many urology practices. Although this is common in other specialties, there is little known about these acquisitions in the field of urology, the Urology Times reports.
A recent Urology Practice study, led by Michael S. Leapman, MD, sought to investigate the trends in sudden and significant private equity acquisitions among urology practices between 2011 and 2021. Leapman is an assistant professor of urology at the Yale School of Medicine, New Haven, Connecticut.
The study identified 69 practice acquisitions by hospital systems, multi-specialty practices, urology practices, and private equity platforms. The change began to emerge in 2016, and since that point, the notable finding is that private equity has emerged as the dominant means of practice acquisition in urology. Read more.
